Asymchem Laboratories (Tianjin) Stock | Price, Analyst Rating & Outlook for 2026

Asymchem Laboratorie...

SZSE:002821

¥ 119,56

¥-2,50 (-2,05%)

119,56 ¥

¥-2,50 (-2,05%)

End-of-day quote: 04/07/2026

Asymchem Laboratories (Tianjin) Stock Value

The analyst rating for SZSE:002821 is currently Outperform.

Outperform

Asymchem Laboratories (Tianjin) Company Info

EPS Growth 5Y

7,86%

Market Cap

¥42,19 B

Long-Term Debt

¥0,02 B

Annual earnings

N/A

Dividend

¥1,28

Dividend Yield

1,07%

Founded

1998

Industry

Health Care

Country

China

Website

Asymchem Laboratories (Tianjin)

ISIN Number

CNE100002BZ6

Website

http://www.asymchem.com.cn

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

¥136,50

14.17%

Last Update: 04/07/2026

Analysts: 9

Highest Price Target ¥145,61

Average Price Target ¥136,50

Lowest Price Target ¥115,43

In the last five quarters, Asymchem Laboratories (Tianjin)’s Price Target has risen from ¥109,00 to ¥170,73 - a 56,63% increase. Eight analysts predict that Asymchem Laboratories (Tianjin)’s share price will increase in the coming year, reaching ¥136,50. This would represent an increase of 14,17%.

Top growth stocks in the health care sector (5Y.)

What does Asymchem Laboratories (Tianjin) do?

Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. Business Segments Contract Development and Manufacturing Segment This segment provides a suite of services that focus on the innovation and commercial application of pharmaceutical technologies. The offerings encompass both clinical stage and commercial s...

Business Segments

Contract Development and Manufacturing Segment

This segment provides a suite of services that focus on the innovation and commercial application of pharmaceutical technologies. The offerings encompass both clinical stage and commercial stage CDMO solutions. In the clinical stage, the company delivers comprehensive services including process development, optimization, analytical services, and scale-up services for small molecule drugs. In the commercial stage, the company offers ton-scale manufacturing for registered starting materials, advanced intermediates, and active pharmaceutical ingredients, assuring throughout the manufacturing process.

Emerging Services Segment

The emerging services segment is also growing and includes cutting-edge offerings like pre-formulation and formulation development, chemical macromolecule CDMO solutions for complex molecular entities, developer biosynthesis solutions, and biologics CDMO solutions tailored for monoclonal antibodies and antibody-drug conjugates. Additionally, the company provides Contract Research Organization (CRO) solutions, which are essential for supporting clinical trials.

Business Strategy

The company aims to fortify its position within the pharmaceutical industry through a comprehensive strategy that focuses on innovation and expansion of its service offerings. It has committed to a “two-wheel drive” development strategy, which emphasizes both core capabilities in contract manufacturing and the exploration of emerging technologies and markets.

To reinforce its R&D capabilities, the company is investing heavily in technology. This initiative is necessary for maintaining a competitive edge in the rapidly evolving pharmaceutical landscape. The company’s R&D efforts are supplemented by collaboration with academic institutions and technology centers, focusing on artificial intelligence applications in areas such as enzyme molecular computing and protein evolution to enhance drug development processes.

The company has also maintained a consistent growth trajectory, supported by continuous investments in its facilities and equipment to enhance production efficiency. The company has established new production plants and enhanced its existing infrastructure to accommodate increasing demands and improve service delivery.

Products and Services

The company provides an extensive array of products and services that span the drug development lifecycle from early-stage R&D to commercial manufacturing.

Contract Manufacturing Services

The company's offerings include contract manufacturing services for both small molecule drugs and biopharmaceuticals.

Clinical Stage Services

The company conducts process development and optimization as well as providing analytical and scale-up services that are crucial for moving new drugs through pre-clinical and clinical trials. These services assist clients in navigating the complex drug development pathways effectively.

Commercial Side

The company excels in large-scale manufacturing, ensuring rigorous quality control throughout. The company is known for its ability to manage the production of registered starting materials and active pharmaceutical ingredients at scale, catering to a diverse range of clients in the global market.

Emerging Services

The emerging services delve into advanced biotechnology areas and include specialized manufacturing solutions for complex drug substances and biologics, solidifying its role as a comprehensive service provider in the biopharmaceutical sector.

Geographical Markets Served

The company has a robust geographical footprint, primarily focusing its services in Mainland China while significantly expanding its market presence overseas.

Customers

The company serves a diverse clientele in the pharmaceutical and biotechnology sectors, catering to a broad spectrum of needs across various stages of drug development. The main categories of customers include pharmaceutical companies engaged in drug discovery and development, biotech firms focusing on innovations in therapeutics, and academic institutions requiring specialized manufacturing services.

Sales and Marketing

The company utilizes a combination of direct and indirect sales and marketing strategies to reach its target customers across the pharmaceutical and biotech industries. It focuses on building strong relationships through personalized engagement with potential clients and invests in marketing efforts that highlight its innovative capabilities and service offerings. Distribution channels are diversified, including digital marketing efforts and participation in industry conferences, reinforcing the company's visibility in the marketplace.

History

Asymchem Laboratories (Tianjin) Co., Ltd. was founded in 1998.

Asymchem Laboratories (Tianjin) Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical services:** 70% **Biotechnology:** 20% **Chemical research and development:** 10% **TOP 3 markets:** **USA:** 45% **China:** 30% **Europe:** 15% Asymchem Laboratories (Tianjin) Co., Ltd. generates the majority of its revenue from pharmaceutical services, driven by the in...

At which locations are the company’s products manufactured?

**Production Sites:** - Tianjin, China - Dunhua, China - Fuzhou, China - Shanghai, China - Wilmington, North Carolina, USA Asymchem Laboratories (Tianjin) Co., Ltd. is a leading company in the contract development and manufacturing (CDMO) sector for the pharmaceutical industry. The company operates...

What strategy does Asymchem Laboratories (Tianjin) pursue for future growth?

**Revenue Growth:** Estimated 18% (2024) **R&D Investments:** Over 10% of revenue (2024) Asymchem Laboratories pursues a growth strategy that is heavily focused on research and development (R&D). The company continuously invests over 10% of its revenue in R&D to strengthen its position...

Which raw materials are imported and from which countries?

**Main raw materials:** Chemical intermediates, fine chemicals, active pharmaceutical ingredients (APIs) **Main importing countries:** USA, Germany, India Asymchem Laboratories (Tianjin) Co., Ltd. is a leading company in the field of contract research and manufacturing for the pharmaceutical indus...

How strong is the company’s competitive advantage?

**Market Share:** Estimated at 10% in the global CDMO market (2025) **R&D Investments:** 12% of revenue (2024) **Customer Satisfaction:** 85% positive feedback (2024) Asymchem Laboratories (Tianjin) Co., Ltd. has established itself as a significant player in the contract development and manuf...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 35% (estimated for 2025) **Insider Buys/Sells:** No significant transactions reported in 2025 The institutional investor share in Asymchem Laboratories is estimated to be around 35%. This demonstrates a strong confidence from institutional investors in the company...

What percentage market share does Asymchem Laboratories (Tianjin) have?

**Market share of Asymchem Laboratories:** Estimated at 8% (2025) **Top competitors and their market shares:** 1. **WuXi AppTec:** 15% 2. **Pharmaron:** 12% 3. **STA Pharmaceutical (WuXi STA):** 10% 4. **Asymchem Laboratories:** 8% 5. **ChemPartner:** 6% 6. **Jiangsu Hengrui Medicine:** 5% 7. **Zhe...

Is Asymchem Laboratories (Tianjin) stock currently a good investment?

**Revenue Growth:** 18% (2024) **R&D Expenses:** 12% of revenue (2024) **Market Share in the CDMO Industry:** 7% (2024) Asymchem Laboratories achieved a revenue growth of 18% in 2024, driven by strong demand for their contract development and manufacturing services (CDMO). The company continuou...

Does Asymchem Laboratories (Tianjin) pay a dividend – and how reliable is the payout?

**Dividend Yield:** 0.8% (2024) **Dividend History:** Continuous payout since 2019 Asymchem Laboratories (Tianjin) Co., Ltd. has distributed dividends in recent years, with the dividend yield standing at approximately 0.8% in 2024. The company has been consistently paying dividends since 2019, indi...

New support ticket

Explore

Asymchem Laboratories (Tianjin) Stock Value

Asymchem Laboratories (Tianjin) Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Asymchem Laboratories (Tianjin) do?

Asymchem Laboratories (Tianjin) Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Asymchem Laboratories (Tianjin) Stock Value

Asymchem Laboratories (Tianjin) Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Asymchem Laboratories (Tianjin) do?

Asymchem Laboratories (Tianjin) Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.